Concepedia

James T. Symanowski

JT

Statistics

Publications

67

Citations

6.5K

H-Index

32

Active since

1995

Affiliations

Levine Cancer Institute(Current)

Carolinas Healthcare System

Carolinas Medical Center

Eli Lilly (United States)

The University of Texas MD Anderson Cancer Center

James T. Symanowski is an author at Levine Cancer Institute specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1995–2024

67

Publications

67

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Nicholas J. Vogelzang, James J. Rusthoven, James T. Symanowski et al. · Journal of Clinical Oncology · 2003 · 3K citations

Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B<sub>12</sub> as Front-Line Therapy in Malignant Pleural Mesothelioma

Giorgio V. Scagliotti, Dong-M. Shin, Hedy L. Kindler et al. · Journal of Clinical Oncology · 2003 · 255 citations

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Nicholas J. Vogelzang, James J. Rusthoven, James T. Symanowski et al. · Journal of Clinical Oncology · 2023 · 251 citations

PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer

R. Wendel Naumann, Robert L. Coleman, Robert A. Burger et al. · Journal of Clinical Oncology · 2013 · 227 citations

A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer

Claire S. Zhu, Paul F. Pinsky, Daniel W. Cramer et al. · Cancer Prevention Research · 2011 · 182 citations · Full text

1–5 of 67